MétaCan
Menu
Back to cohort
Record W2225724055 · doi:10.1093/jnci/djv391

The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative

2015· review· en· W2225724055 on OpenAlexaff
Efstathios Zikos, Corneel Coens, Chantal Quinten, Divine Ediebah, Francesca Martinelli, Irina Ghislain, Madeleine King, Carolyn Gotay, Jolie Ringash, Galina Velikova, Bryce B. Reeve, Eva Greimel, Charles S. Cleeland, Hans‐Henning Flechtner, Joachim Weis, J. Schmucker-Von Koch, Mirjam A. G. Sprangers, Andrew Bottomley

Bibliographic record

VenueJNCI Journal of the National Cancer Institute · 2015
Typereview
Languageen
FieldMedicine
TopicCancer survivorship and care
Canadian institutionsPrincess Margaret Cancer CentreUniversity of TorontoUniversity of British Columbia
FundersMedical Research CouncilPfizer FoundationKoning BoudewijnstichtingEuropean Organisation for Research and Treatment of CancerPfizer
KeywordsMedicineQuality of life (healthcare)Randomized controlled trialNauseaClinical trialCancerMEDLINEConstipationPhysical therapyInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND: The European Organisation for Research and Treatment of Cancer (EORTC) Patient-Reported Outcomes and Behavioural Evidence (PROBE) initiative was established to investigate critical topics to better understand health-related quality of life (HRQOL) of cancer patients and to educate clinicians, policy makers, and healthcare providers. METHODS: The aim of this paper is to review the major research outcomes of the pooled analysis of HRQOL data along with the clinical data. We identified 30 pooled EORTC randomized controlled trials (RCTs), 18 NCIC-Clinical Trials Group RCTs, and two German Ovarian Cancer Study Group RCTs, all using the EORTC QLQ-C30. All statistical tests were two-sided. RESULTS: Evidence was found that HRQOL data can offer prognostic information beyond clinical measures and improve prognostic accuracy in cancer RCTs (by 5.9%-8.3%). Moreover, models that considered both patient- and clinician-reported scores gained more prognostic overall survival accuracy for fatigue (P < .001), vomiting (P = .01), nausea (P < .001), and constipation (P = .01). Greater understanding of the association between symptom and/or functioning scales was developed by identifying physical, psychological, and gastrointestinal clusters. Additionally, minimally important differences in interpreting HRQOL changes for improvement and deterioration were found to vary across different patient populations and disease stages. Finally, HRQOL scores are statistically significantly affected by deviations from the intended time point at which the questionnaire is completed. CONCLUSIONS: The use of existing pooled data shows that it is possible to learn about general aspects of cancer HRQOL and methodology. Our work shows that setting up international pooled datasets holds great promise for understanding patients' unmet psychosocial needs and calls for additional empirical investigation to improve clinical care and understand cancer through retrospective HRQOL analyses.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.183
metaresearch head score (Gemma)0.393
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.183
Threshold uncertainty score0.967

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1830.393
Meta-epidemiology (narrow)0.0020.002
Meta-epidemiology (broad)0.0140.017
Bibliometrics0.0200.017
Science and technology studies0.0010.002
Scholarly communication0.0050.005
Open science0.0030.003
Research integrity0.0040.003
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.343
GPT teacher head0.487
Teacher spread0.144 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations37
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueJNCI Journal of the National Cancer InstituteSame topicCancer survivorship and careFrench-language works237,207